Roche NimbleGen Inc.

Roche NimbleGen Inc., and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006. The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic acid microarrays and related products and services in the research field.